These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V; J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741 [TBL] [Abstract][Full Text] [Related]
6. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity. Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154 [TBL] [Abstract][Full Text] [Related]
7. Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators. Sánchez-Rodríguez MB; Téllez É; Casulleras M; Borràs FE; Arroyo V; Clària J; Sarrias MR Front Immunol; 2022; 13():842996. PubMed ID: 35330909 [TBL] [Abstract][Full Text] [Related]
8. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis. Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681 [TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure. Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V; Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394 [TBL] [Abstract][Full Text] [Related]
10. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis. Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063 [TBL] [Abstract][Full Text] [Related]
11. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis. Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928 [TBL] [Abstract][Full Text] [Related]
12. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575 [TBL] [Abstract][Full Text] [Related]
13. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V; J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350 [TBL] [Abstract][Full Text] [Related]
14. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. Zaccherini G; Aguilar F; Caraceni P; Clària J; Lozano JJ; Fenaille F; Castelli F; Junot C; Curto A; Formentin C; Weiss E; Bernardi M; Jalan R; Angeli P; Moreau R; Arroyo V J Hepatol; 2021 May; 74(5):1117-1131. PubMed ID: 33276029 [TBL] [Abstract][Full Text] [Related]
15. Cell death markers in patients with cirrhosis and acute decompensation. Macdonald S; Andreola F; Bachtiger P; Amoros A; Pavesi M; Mookerjee R; Zheng YB; Gronbaek H; Gerbes AL; Sola E; Caraceni P; Moreau R; Gines P; Arroyo V; Jalan R Hepatology; 2018 Mar; 67(3):989-1002. PubMed ID: 29023872 [TBL] [Abstract][Full Text] [Related]
16. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival. Yan H; Jin S; Liang L; Du J; Aithal GP; Li L Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510 [No Abstract] [Full Text] [Related]
17. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. Hernaez R; Kramer JR; Liu Y; Tansel A; Natarajan Y; Hussain KB; Ginès P; Solà E; Moreau R; Gerbes A; El-Serag HB; Kanwal F J Hepatol; 2019 Apr; 70(4):639-647. PubMed ID: 30590100 [TBL] [Abstract][Full Text] [Related]
18. Hematological ratios in patients with acute decompensation and acute-on-chronic liver failure: prognostic factors. Lashen SA; Salem P; Ibrahim E; Abd Elmoaty D; Yousif WI Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):952-960. PubMed ID: 38829945 [TBL] [Abstract][Full Text] [Related]
19. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure. Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128 [TBL] [Abstract][Full Text] [Related]
20. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis. Markwardt D; Holdt L; Steib C; Benesic A; Bendtsen F; Bernardi M; Moreau R; Teupser D; Wendon J; Nevens F; Trebicka J; Garcia E; Pavesi M; Arroyo V; Gerbes AL Hepatology; 2017 Oct; 66(4):1232-1241. PubMed ID: 28545169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]